Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005681 | spliceosomal complex | 3 | 10 |
GO:0032991 | protein-containing complex | 1 | 10 |
GO:0140513 | nuclear protein-containing complex | 2 | 10 |
GO:1990904 | ribonucleoprotein complex | 2 | 10 |
Related structures:
AlphaFold database: A0A3S7WTI8
Term | Name | Level | Count |
---|---|---|---|
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 10 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 10 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 10 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 10 |
GO:0006396 | RNA processing | 6 | 10 |
GO:0006397 | mRNA processing | 7 | 10 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 10 |
GO:0006807 | nitrogen compound metabolic process | 2 | 10 |
GO:0008152 | metabolic process | 1 | 10 |
GO:0008380 | RNA splicing | 7 | 10 |
GO:0009987 | cellular process | 1 | 10 |
GO:0016070 | RNA metabolic process | 5 | 10 |
GO:0016071 | mRNA metabolic process | 6 | 10 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 10 |
GO:0043170 | macromolecule metabolic process | 3 | 10 |
GO:0044237 | cellular metabolic process | 2 | 10 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0046483 | heterocycle metabolic process | 3 | 10 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:0090304 | nucleic acid metabolic process | 4 | 10 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 343 | 347 | PF00656 | 0.723 |
CLV_C14_Caspase3-7 | 51 | 55 | PF00656 | 0.656 |
CLV_C14_Caspase3-7 | 87 | 91 | PF00656 | 0.719 |
CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.356 |
CLV_NRD_NRD_1 | 151 | 153 | PF00675 | 0.219 |
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.297 |
CLV_NRD_NRD_1 | 242 | 244 | PF00675 | 0.536 |
CLV_NRD_NRD_1 | 352 | 354 | PF00675 | 0.606 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.310 |
CLV_PCSK_KEX2_1 | 242 | 244 | PF00082 | 0.646 |
CLV_PCSK_SKI1_1 | 226 | 230 | PF00082 | 0.480 |
CLV_PCSK_SKI1_1 | 264 | 268 | PF00082 | 0.500 |
CLV_PCSK_SKI1_1 | 275 | 279 | PF00082 | 0.410 |
CLV_PCSK_SKI1_1 | 419 | 423 | PF00082 | 0.639 |
CLV_PCSK_SKI1_1 | 72 | 76 | PF00082 | 0.639 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.644 |
DOC_CYCLIN_RxL_1 | 223 | 230 | PF00134 | 0.309 |
DOC_CYCLIN_RxL_1 | 69 | 77 | PF00134 | 0.498 |
DOC_MAPK_gen_1 | 138 | 144 | PF00069 | 0.336 |
DOC_MAPK_gen_1 | 152 | 159 | PF00069 | 0.222 |
DOC_MAPK_gen_1 | 246 | 255 | PF00069 | 0.480 |
DOC_MAPK_gen_1 | 273 | 282 | PF00069 | 0.492 |
DOC_MAPK_HePTP_8 | 272 | 284 | PF00069 | 0.543 |
DOC_MAPK_MEF2A_6 | 152 | 159 | PF00069 | 0.291 |
DOC_MAPK_MEF2A_6 | 275 | 284 | PF00069 | 0.488 |
DOC_PP2B_LxvP_1 | 155 | 158 | PF13499 | 0.309 |
DOC_USP7_MATH_1 | 108 | 112 | PF00917 | 0.704 |
DOC_USP7_MATH_1 | 118 | 122 | PF00917 | 0.612 |
DOC_USP7_MATH_1 | 131 | 135 | PF00917 | 0.562 |
DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.622 |
DOC_USP7_MATH_1 | 318 | 322 | PF00917 | 0.675 |
DOC_USP7_MATH_1 | 46 | 50 | PF00917 | 0.716 |
DOC_USP7_UBL2_3 | 202 | 206 | PF12436 | 0.401 |
DOC_USP7_UBL2_3 | 419 | 423 | PF12436 | 0.639 |
DOC_WW_Pin1_4 | 63 | 68 | PF00397 | 0.601 |
LIG_14-3-3_CanoR_1 | 10 | 16 | PF00244 | 0.726 |
LIG_14-3-3_CanoR_1 | 109 | 117 | PF00244 | 0.581 |
LIG_14-3-3_CanoR_1 | 279 | 285 | PF00244 | 0.441 |
LIG_Actin_WH2_2 | 280 | 297 | PF00022 | 0.452 |
LIG_APCC_ABBAyCdc20_2 | 71 | 77 | PF00400 | 0.573 |
LIG_FHA_1 | 10 | 16 | PF00498 | 0.638 |
LIG_FHA_1 | 248 | 254 | PF00498 | 0.439 |
LIG_FHA_1 | 74 | 80 | PF00498 | 0.643 |
LIG_FHA_2 | 281 | 287 | PF00498 | 0.499 |
LIG_FHA_2 | 49 | 55 | PF00498 | 0.650 |
LIG_LIR_Nem_3 | 327 | 332 | PF02991 | 0.682 |
LIG_SH3_3 | 137 | 143 | PF00018 | 0.344 |
LIG_SH3_3 | 310 | 316 | PF00018 | 0.561 |
LIG_SH3_3 | 61 | 67 | PF00018 | 0.580 |
LIG_TRAF2_1 | 207 | 210 | PF00917 | 0.349 |
LIG_TRAF2_1 | 296 | 299 | PF00917 | 0.520 |
MOD_CDK_SPxxK_3 | 63 | 70 | PF00069 | 0.529 |
MOD_CK1_1 | 111 | 117 | PF00069 | 0.672 |
MOD_CK1_1 | 121 | 127 | PF00069 | 0.650 |
MOD_CK1_1 | 31 | 37 | PF00069 | 0.718 |
MOD_CK1_1 | 66 | 72 | PF00069 | 0.684 |
MOD_CK1_1 | 73 | 79 | PF00069 | 0.615 |
MOD_CK1_1 | 9 | 15 | PF00069 | 0.663 |
MOD_CK2_1 | 293 | 299 | PF00069 | 0.536 |
MOD_CK2_1 | 318 | 324 | PF00069 | 0.634 |
MOD_GlcNHglycan | 100 | 103 | PF01048 | 0.800 |
MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.480 |
MOD_GlcNHglycan | 122 | 126 | PF01048 | 0.608 |
MOD_GlcNHglycan | 133 | 136 | PF01048 | 0.528 |
MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.648 |
MOD_GlcNHglycan | 305 | 308 | PF01048 | 0.639 |
MOD_GlcNHglycan | 363 | 366 | PF01048 | 0.519 |
MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.672 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.663 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.615 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.709 |
MOD_GSK3_1 | 314 | 321 | PF00069 | 0.664 |
MOD_GSK3_1 | 345 | 352 | PF00069 | 0.698 |
MOD_GSK3_1 | 361 | 368 | PF00069 | 0.509 |
MOD_GSK3_1 | 66 | 73 | PF00069 | 0.693 |
MOD_GSK3_1 | 80 | 87 | PF00069 | 0.734 |
MOD_N-GLC_1 | 280 | 285 | PF02516 | 0.552 |
MOD_N-GLC_1 | 31 | 36 | PF02516 | 0.550 |
MOD_NEK2_1 | 144 | 149 | PF00069 | 0.344 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.635 |
MOD_NEK2_1 | 39 | 44 | PF00069 | 0.682 |
MOD_NEK2_1 | 80 | 85 | PF00069 | 0.628 |
MOD_PIKK_1 | 33 | 39 | PF00454 | 0.715 |
MOD_PKA_1 | 242 | 248 | PF00069 | 0.509 |
MOD_PKA_1 | 70 | 76 | PF00069 | 0.588 |
MOD_PKA_2 | 108 | 114 | PF00069 | 0.522 |
MOD_PKA_2 | 242 | 248 | PF00069 | 0.646 |
MOD_PKA_2 | 85 | 91 | PF00069 | 0.686 |
MOD_PKA_2 | 9 | 15 | PF00069 | 0.724 |
MOD_PKB_1 | 26 | 34 | PF00069 | 0.625 |
MOD_PKB_1 | 273 | 281 | PF00069 | 0.545 |
MOD_Plk_1 | 280 | 286 | PF00069 | 0.552 |
MOD_Plk_1 | 298 | 304 | PF00069 | 0.574 |
MOD_Plk_1 | 400 | 406 | PF00069 | 0.557 |
MOD_Plk_2-3 | 400 | 406 | PF00069 | 0.604 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.693 |
MOD_Plk_4 | 298 | 304 | PF00069 | 0.535 |
MOD_Plk_4 | 70 | 76 | PF00069 | 0.646 |
MOD_ProDKin_1 | 63 | 69 | PF00069 | 0.598 |
MOD_SUMO_for_1 | 205 | 208 | PF00179 | 0.401 |
TRG_ER_diArg_1 | 252 | 255 | PF00400 | 0.469 |
TRG_ER_diArg_1 | 394 | 397 | PF00400 | 0.718 |
TRG_ER_diLys_1 | 422 | 427 | PF00400 | 0.604 |
TRG_NLS_Bipartite_1 | 138 | 156 | PF00514 | 0.401 |
TRG_NLS_MonoExtC_3 | 421 | 426 | PF00514 | 0.563 |
TRG_NLS_MonoExtN_4 | 419 | 426 | PF00514 | 0.636 |
TRG_NLS_MonoExtN_4 | 67 | 74 | PF00514 | 0.508 |
TRG_Pf-PMV_PEXEL_1 | 226 | 230 | PF00026 | 0.473 |
TRG_Pf-PMV_PEXEL_1 | 257 | 261 | PF00026 | 0.454 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0X6 | Leptomonas seymouri | 62% | 77% |
A0A1X0NU15 | Trypanosomatidae | 39% | 93% |
A0A422N165 | Trypanosoma rangeli | 43% | 90% |
A4H876 | Leishmania braziliensis | 83% | 99% |
A4HWK1 | Leishmania infantum | 100% | 100% |
C9ZXT8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 93% |
E9AQA2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4QF81 | Leishmania major | 94% | 100% |